| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-13 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |